News
BTMD
2.210
-5.56%
-0.130
Weekly Report: what happened at BTMD last week (0601-0605)?
Weekly Report · 1d ago
Biote Announces Interim CEO Amid Leadership Transition Plans
TipRanks · 06/02 23:06
Biote reaffirms FY2026 outlook for revenue above $190 million, adjusted EBITDA above $38 million
PUBT · 06/02 21:17
Biote appoints Bajaj as Chief Medical Officer
TipRanks · 06/01 12:38
Biote Appoints Komal Bajaj As CMO
NASDAQ · 06/01 12:32
Biote appoints Komal Bajaj as chief medical officer effective June 1, 2026
PUBT · 06/01 12:05
BIOTE APPOINTS KOMAL BAJAJ, MD, MS AS CHIEF MEDICAL OFFICER
Reuters · 06/01 12:00
Weekly Report: what happened at BTMD last week (0525-0529)?
Weekly Report · 06/01 10:30
Biote announces Christensen to step down as CEO, Peterson named interim CEO
TipRanks · 05/28 14:55
Biote names CFO Bob Peterson as interim CEO, reaffirms FY26 outlook amid leadership shift
Seeking Alpha · 05/28 13:36
Biote Reaffirms FY26 Guidance For Revenue Above $190M And Adjusted EBITDA Above $38M
Benzinga · 05/28 13:12
Biote Appoints CFO And Chief Business Officer Bob Peterson As Interim CEO And Director, Effective June 8; Bret Christensen Steps Down As CEO
Benzinga · 05/28 13:11
*Biote Board Retained Executive Search Firm to Assist With Identification, Evaluation of CFO Candidates >BTMD
Dow Jones · 05/28 13:05
*Biote: Appointment Effective June 8 >BTMD
Dow Jones · 05/28 13:04
*Biote: Chmn Marc Beer to Assume Role of Executive Chmn >BTMD
Dow Jones · 05/28 13:04
*Biote Reaffirms Full Yr 2026 Guidance >BTMD
Dow Jones · 05/28 13:04
*Biote: Bret Christensen Stepping Dn as CEO for Family and Personal Reasons, Remains Director >BTMD
Dow Jones · 05/28 13:03
Biote names CFO Bob Peterson interim CEO as Bret Christensen steps down
PUBT · 05/28 13:02
BIOTE - REAFFIRMS FY2026 GUIDANCE: REVENUE ABOVE $190 MLN, ADJ EBITDA ABOVE $38 MLN
Reuters · 05/28 13:00
*Biote Names Bob Peterson, Current Chief Financial And Chief Business Officer, As Interim CEO >BTMD
Dow Jones · 05/28 13:00
More
Webull provides a variety of real-time BTMD stock news. You can receive the latest news about Biote through multiple platforms. This information may help you make smarter investment decisions.
About BTMD
biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. It also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.